Digital health

Alcimed provided support to a start-up offering eHealth remote monitoring services for outpatients following surgery. Interacting with hospital sector stakeholders (general management, financial management, IT management, heads of department, etc.) enabled us to assess how this solution was received, its market potential and also the means of acquisition and the services most expected by potential buyers.

Our recommendation enabled us to position the solution in a more finely-tuned manner, and highlighted a series of core success factors, particularly in terms of partnerships and specific technical characteristics.

Alcimed provided support to a pharmaceutical stakeholder in exploring and conducting in-depth analysis of start-ups and SMEs offering artificial intelligence services in order to discover new therapeutic candidates. More precisely, the challenge was to put forward preferential partners to conduct the repositioning of molecules (“drug repurposing”).

The result of the project was a recommendation of 4 companies from among upwards of 150 at international level, enabling the subject to be framed for our client but also to provide clear reasoning as to the partnerships upon which to focus in the targeted therapeutic areas.

Alcimed provided support to a pharmaceutical leader positioned in chronic gastrointestinal disease. In this context, the monitoring of patients was somewhat poor, due to that fact that in the absence of severe acute episodes, they do not notice the rather slow progress of the disease and therefore they consult their doctor too irregularly.

In order to develop a digital solution that was relevant in this context, we applied an approach of design thinking, bringing together healthcare professionals and patients. They redefined the issues themselves, clarified the needs and prototyped the ideal solution.

We then supported our client in the search for partners in order to put this solution into practice, and established a roadmap over several years, seeking to demonstrate the solution’s medical benefit.

While telemedicine is a healthcare access channel that is rapidly developing in eHealth, it is also a potential avenue for the industry to implement complementary services for professionals and patients.

Alcimed has provided support to an international pharmaceutical laboratory in building a business case in women’s health, underscoring how services based on teleconsultation platforms could create value.

The project concluded with the implementation of three pilot programs with sector start-ups in France, Germany and Russia.